Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Bandhan Bank Stock Soars 7 percent After RBI Affirms New MD and CEO

    Bandhan Bank Stock Soars 7% After RBI Affirms New MD and CEO


    Finance Outlook India Team | Friday, 11 October 2024

    Bandhan Bank shares rose more than 7% in the morning session after the Reserve Bank of India (RBI) approved Partha Pratim Sengupta to become the new Managing Director and CEO of a private bank.

    Partha Pratim Sengupta accepted the position on October 9, 2024, and indicated on October 10 that he would leave his previous positions in accordance with the RBI's terms and conditions. His three-year tenure is scheduled to begin on November 10, 2024.

    The appointment will be confirmed after receiving approval from the bank's Nomination and Remuneration Committee.

    At 9.30 a.m., Bandhan Bank shares were trading at Rs 200.8 per share, up 7 percent on the NSE from the previous session's closing price.

    Bandhan Bank further reported that the National Credit Guarantee Trustee Company (NCGTC) had completed a rigorous forensic examination of its claims under the Credit Guarantee Fund for Micro Units (CGFMU) scheme. As of March 31, 2024, the total assessed payout stood at Rs 1,231.29 crore.

    The bank had received Rs 916.61 crore in December 2022. According to Bandhan Bank, the final reimbursement as of March 2024 is Rs 314.68 crore, having settled the initial claim.

    International brokerage Jefferies maintained its buy rating on Bandhan Bank, with a target price of Rs 240 per share, noting Partha Sengupta's appointment as Managing Director and CEO as a good move.

    Sengupta's experience in West Bengal, a critical market for the bank, is expected to bolster its standing. Furthermore, the bank expects to earn Rs 320 crore from a CGFMU claim, with Rs 230 crore in recoveries, increasing its profitability and trustworthiness.

    With historical strains alleviated and excellent prices of 1.1 times FY26 adjusted price-to-book, Jefferies advises that investors continue to buy the company.

    International Brokerage Goldman Sachs also stated that the hiring of the MD and CEO, along with the resolution of the CGFMU claim, eliminates all near-term risks. The focus on Bandhan Bank now turns to its fundamentals, as investor concern has been addressed around the continuity of business momentum following the change in management

     



    Read More:

    SkinInspired Bags $2.9 Mn Funding Led by Spring Marketing Capital

    FutureCure Health Secures Rs 104 Cr Funding Led by Carnelian AMC

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us